1 unknown. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Postmenopausal: new trials by email Literature Review of Postmenopausal trials Research Report on Postmenopausal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer Patients Ribociclib, Trastuzumab, Letrozole - HER2-positive Breast Cancer, Postmenopausal | Phase 1 / Phase 2 | Unknown | Yonsei University | 95 | 2019-06-10 | 2022-05-10 |
Breast Neoplasms (1)
Breast Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Letrozole (1) · Trastuzumab (1) · ribociclib (1)
South Korea (1)